Details for Patent: 10,570,202
✉ Email this page to a colleague
Which drugs does patent 10,570,202 protect, and when does it expire?
Patent 10,570,202 protects INLYTA and is included in one NDA.
This patent has thirty-seven patent family members in twenty-one countries.
Summary for Patent: 10,570,202
| Title: | Combination of a PD-1 antagonist and a VEGFR inhibitor for treating cancer |
| Abstract: | The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a VEGFR inhibitor, and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1. |
| Inventor(s): | Martini; Jean-Francois Andre (Carlsbad, CA), Tarazi; Jamal Christo (San Diego, CA), Perini; Rodolfo Fleury (Philadelphia, PA), Mauro; David J. (North Wales, PA) |
| Assignee: | Pfizer Inc. (New York, NY) Merck Sharpe & Dohme Corp. (Rahway, NJ) |
| Application Number: | 15/115,730 |
|
Patent Claim Types: see list of patent claims | Use; Device; Dosage form; |
Drugs Protected by US Patent 10,570,202
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pf Prism Cv | INLYTA | axitinib | TABLET;ORAL | 202324-001 | Jan 27, 2012 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | IN COMBINATION WITH PEMBROLIZUMAB FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA | ⤷ Try a Trial | ||||
| Pf Prism Cv | INLYTA | axitinib | TABLET;ORAL | 202324-002 | Jan 27, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | IN COMBINATION WITH PEMBROLIZUMAB FOR THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,570,202
| PCT Information | |||
| PCT Filed | February 03, 2015 | PCT Application Number: | PCT/US2015/014212 |
| PCT Publication Date: | August 13, 2015 | PCT Publication Number: | WO2015/119930 |
International Family Members for US Patent 10,570,202
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015214390 | ⤷ Try a Trial | |||
| Brazil | 112016017256 | ⤷ Try a Trial | |||
| Canada | 2937521 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
